(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.45%) $79.62
(0.35%) $2.31
(0.59%) $2 354.00
(0.83%) $28.60
(0.22%) $993.00
(-0.31%) $0.927
(-0.39%) $10.85
(-0.24%) $0.798
(0.87%) $92.54
4 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 12.23%
Live Chart Being Loaded With Signals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa...
Stats | |
---|---|
Dagens volum | 73 465.00 |
Gjennomsnittsvolum | 411 391 |
Markedsverdi | 1.66M |
EPS | $0 ( 2024-02-16 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.650 |
ATR14 | $0.00400 (1.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-14 | Hull Andrew | Sell | 42 | Employee Stock Option (Expiration) |
2024-03-04 | Hsu Eric C | Sell | 309 | Employee Stock Option (Expiration) |
2024-01-21 | Mancini Alexandra Diane Janet | Sell | 121 | Employee Stock Option (Expiration) |
2024-02-20 | Jagpal Netta | Sell | 50 000 | Employee Stock Option (Right to Buy) |
2024-02-21 | Hull Andrew | Buy | 37 500 | Common Stock |
INSIDER POWER |
---|
74.87 |
Last 93 transactions |
Buy: 1 291 573 | Sell: 391 310 |
Volum Korrelasjon
InMed Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ZSAN | 0.901 |
KBSF | 0.889 |
BNOX | 0.885 |
AYLA | 0.884 |
ARQQ | 0.884 |
VIH | 0.884 |
LYRA | 0.882 |
QLGN | 0.881 |
LQDT | 0.879 |
DWACU | 0.87 |
10 Mest negative korrelasjoner | |
---|---|
STAY | -0.89 |
AVGO | -0.884 |
TIPT | -0.883 |
BNIXU | -0.876 |
TVTY | -0.875 |
ARDX | -0.874 |
USLM | -0.872 |
LRFC | -0.869 |
LUNA | -0.864 |
PEBK | -0.862 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
InMed Pharmaceuticals Korrelasjon - Valuta/Råvare
InMed Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $4.14M |
Bruttogevinst: | $1.40M (33.93 %) |
EPS: | $-3.25 |
FY | 2023 |
Omsetning: | $4.14M |
Bruttogevinst: | $1.40M (33.93 %) |
EPS: | $-3.25 |
FY | 2022 |
Omsetning: | $1.09M |
Bruttogevinst: | $543 546 (49.89 %) |
EPS: | $-41.74 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-38.00 |
Financial Reports:
No articles found.
InMed Pharmaceuticals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.